<DOC>
	<DOCNO>NCT00869466</DOCNO>
	<brief_summary>RATIONALE : Measuring change body weight body composition woman early-stage breast cancer may help doctor plan best weight control program improve patient ' quality life . It yet know program effective woman breast cancer . PURPOSE : This randomized clinical trial compare three weight control program see well work woman undergone surgery early stage breast cancer .</brief_summary>
	<brief_title>Weight Control Programs Women Who Have Undergone Surgery Early Stage Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - To assess change body weight composition ( i.e. , body fat , fat-free mass , dual energy x-ray absorptiometry , bioelectrical impedance , waist hip circumference ) patient early stage breast cancer . Secondary - To assess uptake retention intervention adverse effect intervention patient . OUTLINE : This multicenter study . Patients stratify accord adjuvant treatment ( chemotherapy v chemotherapy ) , body mass index ( &gt; 27kg/m² v &lt; 27 kg/m² ) , treat hospital ( UHSM vs North Manchester v Royal Oldham v Stepping Hill Hospital ) , high v low risk reduce bone density ( i.e. , patient receive aromatase inhibitor vs premenopausal woman receive chemotherapy and/or tamoxifen v postmenopausal woman receive tamoxifen ) , high v low risk develop lymphedema ( i.e. , axillary node clearance v axillary node clearance ) . Patients randomize 1 3 intervention . - Arm I : Patients receive standard write advice `` Healthy Living With Breast Cancer '' booklet South Manchester University Hospital . - Arm II : Patients receive individualize diet exercise advice study dietitian 40 minute exercise referral officer 40 minute . Advice reinforce 20-minute bi-weekly phone call check compliance , change diet , physical activity , individual problem goal , recommendation . Patients also receive mail information summarize key motivational , behavioral , diet , exercise issue ; information cover group session weight management ; booklet provide program walking , strengthen , tone , flexibility exercise . - Arm III : Patients undergo supervise group community weight control intervention base Courneya 's exercise prescription guideline breast cancer patient survivor . The intervention consist 5-minute warm-up comprise walk movement music , 20-30 minute circuit train approximately 10 station incorporate aerobic activity ( i.e. , brisk walking , cycling , low-level exercise music ) muscle strengthen activity ( i.e. , wall press-up , side leg raise , light weight , resistance band ) , 10-minute cool-down stretch flexibility exercise , 5-minute relaxation period . Patients also undergo 30-minute diet behavior change educational session base trans theoretical model behavior change . The intervention repeat weekly 12 week . Patients receive booklet provide program walking , strengthen , tone , flexibility exercise . Patients also receive booster phone call reinforce advice , problem solve , monitor compliance 4 , 6 , 9 month . In arm , quality life assess baseline 3 , 6 , 12 month . Serum bone marker , insulin , glucose , cardiovascular disease marker measure periodically .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Body Weight Changes</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis early breast cancer Stage IIII disease Invasive situ disease No metastatic inoperable disease Underwent primary surgery primary breast cancer UHSM , North Manchester , Royal Oldham , Stepping Hill , Hope Macclesfield General , Tameside General , Leighton Hospitals , Rochdale Infirmary within past 10 week Receiving/due start adjuvant chemotherapy , radiotherapy , endocrine therapy , adjuvant treatment Hormonal receptor status specify PATIENT CHARACTERISTICS : Pre postmenopausal status Any weight allow Resident within Greater Manchester Cheshire area No physical/psychiatric condition impairs compliance mobility assess medical history baseline fitness assessment , include follow : Insulinrequiring diabetes ( noninsulin require diabetic eligible ) Serious digestive and/or absorptive problem , include inflammatory bowel disease Cardiovascular respiratory disease Musculoskeletal disease joint problem Psychiatric disorder condition ( e.g. , untreated major depression , psychosis , substance abuse , severe personality disorder ) Not consider reconstructive surgery next 12 month PRIOR CONCURRENT THERAPY : See Disease Characteristics No concurrent daily medication know affect body composition ( e.g. , corticosteroid ) Patients receive 23 day steroid chemotherapy eligible No prior neoadjuvant chemotherapy endocrine therapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>weight change</keyword>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage IB breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
</DOC>